At ICV San Francisco 2018, we will host a series of presentations where change-makers and forward-thinking leaders – Family Offices, Fund Investors, Key Opinion Leaders, Academia, and Senior Management from a select group of Companies – will share their ideas and evaluate opportunities that create a social impact beyond a financial return.

 

Investment Community Visibility (ICV) connects family offices and fund investors to evaluate opportunities that create a social impact beyond a financial return. There are few audiences by virtue and wealth that can advance corporate responsibility, capitalize businesses at significant levels, improve the wellbeing of humankind through philanthropy, and influence systemic change in the world.

Innovative research is leading to breakthroughs in medicines, therapies, devices, and technologies which will define the future of healthcare. There will be new treatments capable of curing a myriad of illnesses, thus helping people to live longer, with less pain. Through careful investing, countless lives can be profoundly improved.
 
 

Where is Healthcare in 2030?

 

Bridging the Gap between Academia, Corporations and Capital

 

Can We Cure Cancer In Our Lifetime?

In the last hour, an estimated 192 people were diagnosed with cancer in the United States and every minute, someone dies from cancer in our country. 

 

The Next Giant Leap: Making the Cancer Moonshot a Reality

 

Advancing Innovative Therapeutic Approaches

Key Opinion Leaders and leading Industry-focused Investors who leverage their talent, influence and capital to identify and grow businesses will share their depth of knowledge, insights and outlook.

Endocrinology
Immunology

Neurology
Oncology
 
 

 


 

New Frontier Bio

“Have we the nerve and the will? Can we carry through in an age where we will witness not only new breakthroughs in weapons of destruction, but also a race for mastery of the sky and the rain, the ocean and the tides, the far side of space, and the inside of men’s minds? That is the question of the New Frontier.” – President John F. Kennedy

The Kennedy Family has been involved with healthcare innovation since the 1940s. They endowed the Chair of Neuroscience at Harvard Medical School, founded the National Center for Children and Families at the National Institutes of Health (NIH), and created the Special Olympics, among other things. Ted Kennedy was responsible for overseeing funding for U.S. healthcare research for 40 years, and the family has an unparalleled network of contacts in academic medical centers nationwide. In addition, the family founded two of the largest and most influential nonprofits in neuroscience and healthcare policy innovation (The Kennedy Forum and One Mind for Research) and two very successful healthcare businesses: MEDCO, the nation’s first Plan Benefit Manager, and The Marwood Group, a premier healthcare regulatory and reimbursement risk consulting firm. New Frontier Bio, a holding company co-founded by Stephen Kennedy Smith and Corey McCann, leverages the long-term involvement of the Kennedy family in health care and academia to identify and commercialize transformative medical innovations that have the potential to achieve early stage validation, transform millions of lives, and become highly valuable businesses.

  • Stephen Kennedy Smith is a principal at Park Agency – Joseph P. Kennedy Enterprises, the Kennedy family office, and an investor and entrepreneur. He has served as a director or advisor to several companies, including Gridline Communication Holdings, Pear Therapeutics, Owl Biomedical, and LocoMobi. His current investment and business focus is scaling innovative healthcare, and neuroscience companies. Stephen is a board member of the John F. Kennedy Library and The Joseph P. Kennedy Foundation. He also serves on the advisory board at INCAE Business School. He is cofounder and vice president of the World Leadership Alliance, an organization of business and political leaders that promotes, democracy, international understanding and trade. Stephen is currently a lecturer at the Sloan school of Management in the visionary investing program, as well as a fellow at the Connection Science Group at MIT. He holds an M.A. from Harvard University, a J.D. from Columbia University, and an M.A. Ed. from Harvard’s School for Education. He has served on the staff of the Senate Judiciary and Foreign Relations Committees and is a three-time recipient of the Danforth Award for Excellence in Teaching at Harvard University.
  • Corey McCann, MD, PhD has background as a physician, scientist, entrepreneur, and healthcare investor. Previously, he was an investor with MPM Capital and with RiverVest Venture Partners, where he evaluated new investment opportunities, managed relationships with strategic partners, and oversaw board-level strategy and execution at portfolio companies. Prior to MPM, he was with McKinsey & Company, where he advised pharmaceutical, medical device, and biotechnology companies on the acquisition, development, and commercialization of life science technologies. He also led McKinsey’s Central Nervous System (CNS) expertise group, serving clients across pharma and biotech. He is a founding member of multiple start-ups including Alcyone Lifesciences, a company developing technologies to deliver therapeutics to the brain. Dr. McCann’s post-graduate training was at Harvard University, Washington University in St Louis, and at the Massachusetts General Hospital, and he graduated summa cum laude from The Pennsylvania State University where he was an Evan Pugh Scholar.

 

Championing Women’s Health, Equality and Empowerment

A discussion on women’s health and economic and political empowerment, including access to decent work, and control over economic, and productive resources and active participation in governance and decision-making.

 
Maternal Health in the Era of the Sustainable Development Goals

Maternal mortality is one of the most pronounced health inequities between high income and resource constrained countries. For example, a woman in sub-Saharan Africa is 45 times more likely to die during pregnancy or childbirth than her counterpart in the developed world. Hear how the Sustainable Development Goals aim to reduce maternal mortality by more than 50% and new technologies and practices that will help to reach this target.
 
 

Innovations in Population Health

When it comes to population health, social determinants of health (e.g., poverty and education) are the key to wellness in our society.

 
Nutrition & Integrative Medicine: The Most Powerful Drug is Food

Proper nutrition is more important to the achievement and preservation of health than prescription medications and supplements. Food intake has been traditionally associated with calories, and less understood in its other biological interactions. We know now that food is actually information like software disks in computers. Insert the wrong disk or a virus and you know what happens. The truth is that food influences gene expression. Eating changes cells and bodily functions through foods’ communication with hormones and genes. Healthy cellular communication resulting from proper food choices leads to a healthy body with good genetic expression and overall well-being. Inappropriate food choices cause unhealthy communication leading to dysfunction and disease. Genomic testing provides helpful information to create an optimal diet customized to each person. Targeted dietary changes empower individuals to operate beyond the, “What can you do anyway, it’s nobody’s fault… It’s all in your genes” approach most people have been led to believe. At FWSI, we evaluate you as an individual and provide clear, science-based instructions on eating to improve your health, strengthen your biochemistry, protect yourself against diseases, and work toward reversing imbalances within your body.

 
The Power of Mindfulness & Meditation: Reshape Your Brain

Mindfulness is about paying attention. It’s about living your life in the richness of right now, not being lost in memories of the past or overwhelmed by the worries or projections of the future. It’s a simple practice that strengthens the mind’s ability to stay focused on what is happening right now and to be open to experience — meeting the present moment with kindness and nonreactivity.